Allen Chao

Allen Chao

Signal active

Director

Bio

Dr. Chao was a co-founder of Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, serving as a director from 1985 to May 2008, Chairman of the Board of Directors from May 1996 to May 2008, and Chief Executive Officer from 1985 to September 2007. While at Watson, Dr. Chao oversaw the company’s growth, through internal R&D, licensing and acquisitions of pharmaceutical products and technologies, as well as mergers and acquisition activities.

Dr. Chao received a Ph.D. in industrial and physical pharmacy from Purdue University in 1973. In May of 2000, he received the degree of Doctor of Science from Purdue in recognition of his leadership and vision for the production and marketing of pharmaceutical products.

Location

N/A

Social

N/A

Primary Organization

Arbor Pharmaceuticals

Arbor Pharmaceuticals

Founded

2006

Employees

501-1000

Industry

Biotechnology, Life Science, Pharmaceutical

Jobs history

2

Actavis

Founder

Invalid date - Current

Tanvex BioPharma

Founder & CEO

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Allen Chao is the Director at Arbor Pharmaceuticals, based in Asia. With a background in Biotechnology, Allen Chao has a rich history of leadership and innovation. Allen Chao studied Ph.D industrial and physical pharmacy @ Purdue University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

Allen Chao has made 1 investments. Their Latest investment was Seed Round - Zephyr AI on Mar 30, 2022

Number of investment

1

Number of exits

1

Personal investment

1

Annouced DateOrganization NameFunding RoundMoney Raised
Mar 30, 2022
Zephyr AI Zephyr AI
Seed Round - Zephyr AI
18.5M

Partner investment

0

There is no partner investment available on this profile

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.